Cytokinetics (CYTK) Return on Equity [ROE] (2009 - 2024)
Cytokinetics (CYTK) reported Return on Equity [ROE] of -1184.61% for Q3 2024.
Powered by 
Analysis
Cytokinetics (CYTK) Return on Equity [ROE] (2009 - 2024) Analysis & Trends
For FY2022, Cytokinetics posted Return on Equity [ROE] of -505.46%, down 391.95 percentage points from FY2021.
- Return on Equity [ROE] has a five-year change of -391.44 percentage points (FY2017 to FY2022).
- By year, Return on Equity [ROE] came in at -113.51% in FY2021 (+101.05 pp), -214.56% in FY2020 (+1192.25 pp), -1406.81% in FY2019 (-1270.25 pp) and -136.57% in FY2018 (-22.55 pp).
- The Q3 2024 figure ranks as the highest quarterly Return on Equity [ROE] in data going back to Q3 2011.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Cytokinetics | 7.83 Bn | 3.24 Bn | 47.10 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | -1,204.88% |
| Sep 30, 2022 | -602.78% |
| Jun 30, 2022 | -193.60% |
| Mar 31, 2022 | -145.11% |
| Dec 31, 2021 | -87.78% |
| Sep 30, 2021 | -173.02% |
| Jun 30, 2021 | -372.61% |
| Mar 31, 2021 | -150.70% |
| Dec 31, 2020 | -97.21% |
| Sep 30, 2020 | -318.10% |
| Mar 31, 2019 | -718.33% |
| Dec 31, 2018 | -272.12% |
| Sep 30, 2018 | -189.07% |
| Jun 30, 2018 | -148.89% |
| Mar 31, 2018 | -125.77% |
| Dec 31, 2017 | -99.33% |
| Sep 30, 2017 | -49.67% |
| Jun 30, 2017 | -10.91% |
| Mar 31, 2017 | 3.03% |
| Dec 31, 2016 | 18.36% |
API Access
Cytokinetics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CYTK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "CYTK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CYTK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();